ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Prostatic Cancer

Adenocarcinoma trials near Rochester, MN, USA:

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PRISM-1)

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 3

Arcus Biosciences
Arcus Biosciences

Rochester, Minnesota, United States and 32 other locations

Cohort 1 \[CLOSED\] Study treatment involves two segments: (1) Induction Immunotherapy segment with pembrolizumab monotherapy every 3 weeks until irR...

Enrolling
Adenocarcinoma
Gastric Cancer
Drug: Ramucirumab
Drug: Paclitaxel

Phase 2

Harry H Yoon

Rochester, Minnesota, United States and 1 other location

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Enrolling
PDAC - Pancreatic Ductal Adenocarcinoma
PDAC
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Rochester, Minnesota, United States and 24 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 206 other locations

Locations recently updated

This research is designed to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN1...

Enrolling
Esophageal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Drug: AZD5863

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 24 other locations

This is a Phase 1/2 study to assess the safety and efficacy of ELI-002 7P immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
KRAS G12V
Drug: ELI-002 7P

Phase 1, Phase 2

Elicio Therapeutics
Elicio Therapeutics

Rochester, Minnesota, United States and 27 other locations

This phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vacci...

Enrolling
Recurrent Fallopian Tube Clear Cell Adenocarcinoma
Recurrent Fallopian Tube Endometrioid Adenocarcinoma
Procedure: Pheresis
Procedure: Magnetic Resonance Imaging

Phase 1, Phase 2

Mayo Clinic
Mayo Clinic

Rochester, Minnesota, United States and 2 other locations

This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced,...

Enrolling
Pancreatic Adenocarcinoma
Solid Tumor
Drug: MRTX1719

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Rochester, Minnesota, United States and 20 other locations

The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6)...

Active, not recruiting
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Drug: Bemarituzumab
Drug: mFOLFOX6

Phase 3

Amgen
Amgen

Rochester, Minnesota, United States and 300 other locations

This is an open-label, dose-exploration and expansion study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminar...

Enrolling
Pancreatic Adenocarcinoma
Non-small Cell Lung Cancer (NSCLC)
Drug: IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)
Drug: IMM-1-104 + modified FOLFIRINOX (Treatment Group C)

Phase 1, Phase 2

Immuneering Corporation

Rochester, Minnesota, United States and 19 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems